Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
AIDS Dementia Complex D015526 4 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Burns, Inhalation D002059 4 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Brain Injuries D001930 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lukashova V et al. G-protein-independent activation of Tyk2 by the platelet-activating factor receptor. 2001 J. Biol. Chem. pmid:11309383
Grassi S and Pettorossi VE Synaptic plasticity in the medial vestibular nuclei: role of glutamate receptors and retrograde messengers in rat brainstem slices. 2001 Prog. Neurobiol. pmid:11311461
Marcano H et al. Effect of dopamine on platelet activating factor induced-pulmonary edema in isolated and perfused rabbit lungs. 2001 Respir Physiol pmid:11348642
Wild MD and Roudebush WE Platelet-activating factor improves intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11349157
Wu C et al. Evidence for the autocrine induction of capacitation of mammalian spermatozoa. 2001 J. Biol. Chem. pmid:11350972
Taylor R et al. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction. 2001 Clin. Sci. pmid:11352774
Hayashi J et al. Platelet-activating factor antagonist, SM-12502, attenuates experimental glomerular thrombosis in rats. 2001 Nephron pmid:11287764
Choi JH et al. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. 2001 J. Immunol. pmid:11290796
Marathe GK et al. Identification of platelet-activating factor as the inflammatory lipid mediator in CCl4-metabolizing rat liver. 2001 J. Lipid Res. pmid:11290831
Kato M et al. Platelet activating factor degradation in tear fluid from guinea pigs with allergic conjunctivitis. 2001 J Ocul Pharmacol Ther pmid:11327052
Caplan MS et al. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. 2001 Pediatr. Res. pmid:11328947
Sugano T et al. Effects of platelet-activating factor on cytokine production by human uterine cervical fibroblasts. 2001 Mol. Hum. Reprod. pmid:11331671
Taylor KE et al. Could platelet activating factor play a role in developmental dyslexia? 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11334553
Gu M et al. Role of platelet-activating factor in hepatectomy with Pringle's maneuver. 2001 J. Surg. Res. pmid:11266278
Gujrati VR and Sastry BV Metabolic fate of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by human spermatozoa: biosynthesis and biodegradation. 2001 Life Sci. pmid:11270625
Tong N et al. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. 2001 Eur. J. Neurosci. pmid:11403684
Roudebush WE Role of platelet-activating factor in reproduction: sperm function. 2001 Asian J. Androl. pmid:11404790
Briton-Jones C et al. The effects of follicular fluid and platelet-activating factor on motion characteristics of poor-quality cryopreserved human sperm. 2001 J. Assist. Reprod. Genet. pmid:11411433
Mizuno S et al. Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells. 2001 Dig. Dis. Sci. pmid:11414308
Tsoukatos DC et al. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. 2001 Biochem. J. pmid:11439095
Roudebush WE and Diehl JR Platelet-activating factor content in boar spermatozoa correlates with fertility. 2001 Theriogenology pmid:11396471
Bassi F et al. Detection of platelet-activating factor in gingival tissue surrounding failed dental implants. 2001 J. Periodontol. pmid:11210074
Ferland C et al. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. 2001 J. Leukoc. Biol. pmid:11358986
de Meis L Role of the sarcoplasmic reticulum Ca2+-ATPase on heat production and thermogenesis. 2001 Biosci. Rep. pmid:11725862
Tavakoli S et al. Prostaglandin E(2)-induced interleukin-6 release by a human airway epithelial cell line. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11133502
Varon D and Brill A Platelets cross-talk with tumor cells. 2001 Haemostasis pmid:11990484
Del Sorbo L et al. Tat-induced platelet-activating factor synthesis contributes to the angiogenic effect of HIV-1 Tat. 2001 Eur. J. Immunol. pmid:11180101
Karasawa K [Physiological role of novel metabolic pathway of platelet-activating factor(PAF): PAF-dependent transacetylation]. 2001 Tanpakushitsu Kakusan Koso pmid:11193332
Urasaki T et al. Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway. 2001 J. Leukoc. Biol. pmid:11200053
Petty HR and Kindzelskii AL Dissipative metabolic patterns respond during neutrophil transmembrane signaling. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11248046
Hauser CJ et al. PAF-mediated Ca2+ influx in human neutrophils occurs via store-operated mechanisms. 2001 J. Leukoc. Biol. pmid:11200069
Jeon SY et al. Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways. 2001 Ann. Otol. Rhinol. Laryngol. pmid:11201815
Wittwer T et al. Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation. 2001 J. Heart Lung Transplant. pmid:11257563
Clavijo LC et al. PAF increases vascular permeability without increasing pulmonary arterial pressure in the rat. 2001 J. Appl. Physiol. pmid:11133918
Ko TC et al. Synthesis of 4-alkoxy-2-phenylquinoline derivatives as potent antiplatelet agents. 2001 Bioorg. Med. Chem. Lett. pmid:11212091
Taggart DP Effects of a platelet-activating factor antagonist on lung injury and ventilation after cardiac operation. 2001 Ann. Thorac. Surg. pmid:11216754
Lash GE and Legge M Localization and distribution of platelet activating factor receptors in the mouse ovary and oviduct during the estrous cycle and early pregnancy. 2001 Am. J. Reprod. Immunol. pmid:11216875
Sun Z et al. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion. 2001 Scand. J. Gastroenterol. pmid:11218240
Kwan ML et al. Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11159008
Komori M et al. PAF mediates cigarette smoke-induced goblet cell metaplasia in guinea pig airways. 2001 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:11159026
McManus LM et al. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. 2001 J. Leukoc. Biol. pmid:11527989
Stojanov T and O'Neill C In vitro fertilization causes epigenetic modifications to the onset of gene expression from the zygotic genome in mice. 2001 Biol. Reprod. pmid:11159375
Qian C et al. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. 2001 Pharmacol. Res. pmid:11529688
Persidsky Y et al. Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. 2001 J. Neuroimmunol. pmid:11240016
Jerkić M et al. The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I. The role of increased vasoconstriction. 2001 Int Urol Nephrol pmid:11989542
Kawaguchi A et al. Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity. 2001 Life Sci. pmid:11228102
Pettorossi VE and Grassi S Different contributions of platelet-activating factor and nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2001 Acta Otolaryngol Suppl pmid:11677732
Wielockx B et al. Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor. 2001 J. Hepatol. pmid:11682033
Dutra PM et al. Platelet-activating factor modulates a secreted phosphatase activity of the trypanosomatid parasite Herpetomonas muscarum muscarum. 2001 Curr. Microbiol. pmid:11683365
Mathison R et al. Regulation of leukocyte adhesion to heart by the tripeptides feG and feG(NH2). 2001 Can. J. Physiol. Pharmacol. pmid:11599779
Havt A et al. The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. 2001 Toxicon pmid:11600146
Claman P Platelet activating factor does not improve intrauterine insemination outcome. 2001 Am. J. Obstet. Gynecol. pmid:11717679
Caplan MS and Jilling T The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis. 2001 Lipids pmid:11724457
Kaul DK et al. Ameliorating effects of fluorocarbon emulsion on sickle red blood cell-induced obstruction in an ex vivo vasculature. 2001 Blood pmid:11698300
Casao MA et al. Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies. 2001 J. Med. Microbiol. pmid:11699593
Lendvai B et al. Platelet-activating factor evokes Ca2+ transients after the blockade of ryanodine receptor by dantrolene in RAW 264.7 macrophages. 2001 Neurochem. Res. pmid:11699928
Houghton TJ et al. Efficient assembly of the phomactin core via two different macrocyclization protocols. 2001 Org. Lett. pmid:11700095
Adams JM et al. Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock. 2001 Crit. Care Med. pmid:11700422
Masuhara K et al. Involvement of platelet activation in experimental osteonecrosis in rabbits. 2001 Int J Exp Pathol pmid:11703540
Bernatchez PN et al. Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways. 2001 Br. J. Pharmacol. pmid:11704645
Ibe BO et al. Maturational changes in ovine pulmonary metabolism of platelet-activating factor: implications for postnatal adaptation. 2001 Mol. Genet. Metab. pmid:11708870
Suwaki T et al. Modification of eosinophil function by suplatast tosilate (IPD), a novel anti-allergic drug. 2001 Int. Immunopharmacol. pmid:11710545
Macphee CH Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target. 2001 Curr Opin Pharmacol pmid:11714085
Khoo C et al. Inhibition of store-operated Ca(2+) influx by acidic extracellular pH in cultured human microglia. 2001 Glia pmid:11571781
Stafforini DM PAF acetylhydrolase gene polymorphisms and asthma severity. 2001 Pharmacogenomics pmid:11535107
Steer ML Relationship between pancreatitis and lung diseases. 2001 Respir Physiol pmid:11535257
Tokutomi T et al. Production of platelet-activating factor by neuronal cells in the rat brain with cold injury. 2001 Neurol. Res. pmid:11547929
Chemler SR et al. Enantioselective synthesis of the oxadecalin core of phomactin A via a highly stereoselective Diels-Alder reaction. 2001 Org. Lett. pmid:11554815
Kavakli K et al. Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease. 2001 Haemophilia pmid:11554936
Rozenfeld RA et al. Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11557516
Stoddart NR et al. Exogenous platelet-activating factor stimulates cell proliferation in mouse pre-implantation embryos prior to the fourth cell cycle and shows isoform-specific stimulatory effects. 2001 Zygote pmid:11510473
Feldman C et al. Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro. 2001 Eur. Respir. J. pmid:11510782
Mooren FC et al. Decoupling of intracellular calcium signaling in granulocytes after exhaustive exercise. 2001 Int J Sports Med pmid:11510867
Hermoso M et al. Platelet activating factor increases ciliary activity in the hamster oviduct through epithelial production of prostaglandin E2. 2001 Pflugers Arch. pmid:11484763
Sachais BS Platelet-endothelial interactions in atherosclerosis. 2001 Curr Atheroscler Rep pmid:11487452
Jantan I et al. Inhibition of platelet-activating factor receptor binding by aporphine and phenanthrenoid alkaloids from Aromadendron elegans. 2001 Planta Med. pmid:11488464
Hu LH et al. Synthesis and biological activity of amide derivatives of ginkgolide A. 2001 J Asian Nat Prod Res pmid:11491398
Alvarez A and Sanz MJ Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. 2001 J. Leukoc. Biol. pmid:11493611
Raggers RJ et al. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor. 2001 Biochem. J. pmid:11463358
Hollmann MW et al. Local anesthetic effects on priming and activation of human neutrophils. 2001 Anesthesiology pmid:11465548
Lane JS et al. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis. 2001 J. Surg. Res. pmid:11469912
Thomet OA et al. Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus. 2001 Biochem. Pharmacol. pmid:11286996
Velasquez LA et al. PAF receptor and PAF acetylhydrolase expression in the endosalpinx of the human Fallopian tube: possible role of embryo-derived PAF in the control of embryo transport to the uterus. 2001 Hum. Reprod. pmid:11473946
Akisu M et al. The role of recombinant human erythropoietin in lipid peroxidation and platelet-activating factor generation in a rat model of necrotizing enterocolitis. 2001 Eur J Pediatr Surg pmid:11475112
Chang PY et al. Oxidized low-density lipoprotein downregulates endothelial basic fibroblast growth factor through a pertussis toxin-sensitive G-protein pathway: mediator role of platelet-activating factor-like phospholipids. 2001 Circulation pmid:11479258
Küçükhüseyin C et al. Renovascular actions of adenosine in the isolated perfused rat kidney: possible underlying mechanisms. 2001 J Basic Clin Physiol Pharmacol pmid:11868905
Tibiriçá E Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants. 2001 Cardiovasc Drug Rev pmid:11830750
Burke JR et al. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. 2001 J. Pharmacol. Exp. Ther. pmid:11408565
Murakami M et al. Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. 2001 J. Biol. Chem. pmid:11106649
Ottino P and Bazan HE Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites. 2001 Curr. Eye Res. pmid:11840344
Ribeiro JM and Francischetti IM Platelet-activating-factor-hydrolyzing phospholipase C in the salivary glands and saliva of the mosquito Culex quinquefasciatus. 2001 J. Exp. Biol. pmid:11807106
Shah BH et al. Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine. 2001 Exp. Mol. Med. pmid:11795484
Cao YZ et al. Selenium modulates 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) biosynthesis in bovine aortic endothelial cells. 2001 Antioxid. Redox Signal. pmid:11813988
den Dekker E et al. Biogenesis of G-protein mediated calcium signaling in human megakaryocytes. 2001 Thromb. Haemost. pmid:11686331
Tohda Y et al. Role of chemical mediators in airway hyperresponsiveness in an asthmatic model. 2001 Respiration pmid:11223734
Tsai MH et al. Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells. 2001 Int. J. Oncol. pmid:11605008
Fabi F et al. Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways. 2001 Br. J. Pharmacol. pmid:11606318
Añel RL and Kumar A Experimental and emerging therapies for sepsis and septic shock. 2001 Expert Opin Investig Drugs pmid:11772263
Min JH et al. Platelet-activating factor acetylhydrolases: broad substrate specificity and lipoprotein binding does not modulate the catalytic properties of the plasma enzyme. 2001 Biochemistry pmid:11294621
Berdyshev EV et al. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. 2001 FASEB J. pmid:11641243